Objectives:

1. Learn the importance of an early molecular response,

2) Understand treatment recommendations,

3) Review the outcomes from prospective discontinuation trials

 

 

Session date: 
03/06/2017 - 12:00pm to 1:00pm CST
Location: 
UCMC KCBD
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Richard Larson & Daniel Catenacci, M.D